What You Should Know:
– US drug distributor Cardinal Health has signed a $1.9B agreement to acquire a majority stake in Solaris Health from Lee Equity Partners. The deal is aimed at expanding the Specialty Alliance, Cardinal Health’s multi-specialty management services organization (MSO) platform.
– The acquisition will give Cardinal Health a stake of around 75% in Solaris Health. The transaction is expected to be completed by the end of this year, pending customary closing conditions.
Expanding Urology Services to Meet Growing Needs
The acquisition will create the Urology Alliance, a new collaborative network of urology providers within Cardinal’s Specialty Alliance MSO. This move aligns with the company’s broader urologic strategy, which has included recent acquisitions of Urology America, Potomac Urology, and Academic Urology & Urogynaecology.
The deal comes at a critical time, as the US faces a significant shortage of urologists. According to research, 62% of US counties lack a practicing urologist, and for every ten urologists who retire, only one new one enters the field. This shortage contributes to delayed diagnoses, increased rates of advanced-stage conditions, and significant health disparities, particularly in rural communities.
Financial Performance and Market Reaction
The acquisition announcement coincided with the release of Cardinal Health’s Q4 2025 financials. The company’s profits per share were $2.08, which beat the forecasted $2.03. However, quarterly profits were $60.2B, falling short of the $60.92B forecast. This prompted a pre-market stock drop of more than 11% on August 12. Since then, the share price has recovered slightly, with a drop of around 6% to $147.05 per share, down from $157.66 per share at market close on August 11.
